News

Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate ... AlphaFold’s success would pave the way for Isomorphic Labs, a spinoff focused on AI-driven drug discovery. Isomorphic was founded in ...
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue on its mission to create new drugs and medicines using AI.
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital ...
There has been much speculation over how AI will help with healthcare, but some experts believe it can have a dramatic impact ...
The system would go on to win a Nobel Prize in chemistry. It also helped Murdoch, and Isomorphic's founder Demis Hassabis, decide on an ultimate goal: to "solve all disease" through AI-powered ...